infectious-disease
HIV Needle-Stick Risk Assessment Stratification Protocol (RASP)
Structured risk stratification tool guiding post-exposure prophylaxis (PEP) decisions following occupational or non-occupational HIV exposure. Considers source HIV status, exposure type, and clinical context to determine PEP indication.
References
- BHIVA/BASHH/BIS. UK guideline for the use of HIV post-exposure prophylaxis 2021. HIV Medicine. 2022;23(Suppl 4):s1–s87.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Enoxaparin (VTE Prophylaxis — Post-Surgery) · Low Molecular Weight Heparin (LMWH) — VTE Prophylaxis
- Rivaroxaban (Perioperative VTE Prophylaxis) · Direct Oral Anticoagulant — VTE Prophylaxis Post-Surgery
- Lisinopril (HFrEF / Post-MI) · ACE Inhibitor / HFrEF
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Clopidogrel (ACS / Post-PCI) · Antiplatelet / ACS
Pathways
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.